Skip to content

News Category: Health & Medical

Nippon Express Obtains GDP Certification of Compliance with WHO Standards at 2 Domestic Locations: West Japan Pharmaceutical Center and Kyushu Pharmaceutical Center

By asianet

– Storage and Transport Offered in Two Temperature Ranges, Following East Japan Pharmaceutical Center – Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) certification for its West Japan Pharmaceutical Center (Neyagawa City, Osaka Prefecture) and Kyushu Pharmaceutical Center (Kitakyushu City, Fukuoka Prefecture), … Continued

BGI COLOTECT 3.0 demonstrates higher colorectal cancer detection sensitivity than FIT

By asianet

COLOTECT 3.0, a multi-target fecal DNA test outperforms fecal immunochemical tests (FIT) in terms of detection of colorectal cancer and advanced precancerous lesions BGI Genomics, a global life sciences company providing integrated solutions of precision medicine, presented case-control study data on its COLOTECT 3.0 non-invasive colorectal cancer screening test at the 2023 ASCO Gastrointestinal Cancers … Continued

SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan

By asianet

SONIRE Therapeutics Inc. (hereinafter referred to as “SONIRE”), based in Tokyo, announces that it has commenced a randomized phase 2 study for the treatment of unresectable pancreatic cancer with SONIRE’s next-generation High-Intensity Focused Ultrasound (HIFU) therapy system (development code: Suizenji). Logo: https://kyodonewsprwire.jp/prwfile/release/M107547/202301272458/_prw_PI1fl_1823Ko1T.jpg The 5-year survival rate of pancreatic cancer is very low at 8.5%, and … Continued

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

By asianet

DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biopharmaceutical company focused on developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an … Continued

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

By asianet

— Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. DiscGenics, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3764995-1&h=3788254259&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics%2C+Inc. ), a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain … Continued

Youtheory(R) Collagen Liquid Expands Beauty On-The-Go Product in Japan

By asianet

Southern California based supplement brand Youtheory(R) ( https://c212.net/c/link/?t=0&l=en&o=3760761-1&h=2289870515&u=https%3A%2F%2Fyoutheory.com%2Fshop%2Fcollagen-liquid%2F&a=Youtheory%C2%AE ) is expanding its global beauty line with a new and improved Collagen Liquid in a ready-to-drink, single serve packet, now available at Costco Japan ( https://c212.net/c/link/?t=0&l=en&o=3760761-1&h=393580167&u=https%3A%2F%2Fwww.costco.co.jp%2F&a=Costco+Japan ). This liquid is designed for beauty conscious consumers who want to maintain their daily routine during their fast-paced, busy … Continued

PANDORUM INTERNATIONAL ENGAGES EVOLUTION LIFE SCIENCE PARTNERS

By asianet

PANDORUM International Inc. has engaged EVOLUTION Life Science Partners to assist the company in raising capital to fund the ongoing development of its assets, primarily Bioengineered Liquid Cornea, advanced therapeutics to promote cornea regeneration. The capital would support the clinical translation of the first in class, first in human tissue regenerative reprogramming treatment via Phase … Continued

Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA

By asianet

— Company achieves Top Performer status in ISR IRT Benchmark Survey Suvoda LLC ( https://c212.net/c/link/?t=0&l=en&o=3756407-1&h=3282413622&u=https%3A%2F%2Fwww.suvoda.com%2F%3Futm_medium%3Dpress-release%26utm_source%3Dpress-release%26utm_campaign%3Dmomentum-release-2023%26utm_content%3Dpress-release-momentum-2023-01&a=Suvoda+LLC ) , a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%, a strong indicator … Continued

Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campus

By asianet

– Designed and validated to handle high potent molecules less than 1 microgram/m3 containment – First commercial production batch has commenced Sai Life Sciences, one of India’s fastest growing Contract Research [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=hpapi-bidar ] , Development & Manufacturing Organizations [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=hpapi-bidar ] (CRO-CDMO), today announced the opening of a new High-Potency API (HPAPI) manufacturing facility … Continued